Analysis of serum placental growth factor levels in preeclamptic and normotensive pregnant women in Lagos, Nigeria: a worthwhile screening tool?

References

• Abodeely A, Roye GD, Harrington DT, Cioffi WG. 2008. Pregnancy outcomes after bariatric surgery: maternal, fetal, and infant implications. Surgery for Obesity and Related Diseases 4:464–471.
   PubMed Web of Science ®Google Scholar
• ACOG 2020. Practice bulletin, number 222. Gestational hypertension and preeclampsia. Obstetrics & Gynecology 135:e237–e260.
   PubMed Web of Science ®Google Scholar
• ACOG 2013. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstetrics & Gynecology 122:1122–1131.
   PubMed Web of Science ®Google Scholar
• Agrawal S, Shinar S, Cerdeira AS, Redman C, Vatish M. 2019. Predictive Performance of PlGF (Placental Growth Factor) for screening preeclampsia in asymptomatic women: a systematic review and meta-analysis. Hypertension 74:1124–1135.
   PubMed Web of Science ®Google Scholar
• Anorlu RI, Iwuala NC, Odum CU. 2005. Risk factors for pre-eclampsia in Lagos, Nigeria. The Australian and New Zealand Journal of Obstetrics and Gynaecology 45:278–282.
   PubMed Web of Science ®Google Scholar
• Bersinger NA, Groome N, Muttukrishna S. 2002. Pregnancy-associated and placental proteins in the placental tissue of normal pregnant women and patients with pre-eclampsia at term. European Journal of Endocrinology 147:785–793.
   PubMed Web of Science ®Google Scholar
• Bodnar LM, Ness RB, Markovic N, Roberts JM. 2005. The risk of preeclampsia rises with increasing prepregnancy body mass index. Annals of Epidemiology 15:475–482.
   PubMed Web of Science ®Google Scholar
• Charan J, Biswas T. 2013. How to calculate sample size for different study designs in medical research. Indian Journal of Psychological Medicine 35:121–126.
   PubMedGoogle Scholar
• Dover N, Gulerman HC, Celen S, Kahyaoglu S, Yenicesu O. 2013. Placental growth factor: as an early second trimester predictive marker for preeclampsia in normal and high-risk pregnancies in a Turkish population. Journal of Obstetrics and Gynaecology of India 63:158–163.
   PubMedGoogle Scholar
• Gagnon A, Wilson RD, Audibert F, Allen VM, Blight C, Brock J-A, et al. 2008. Obstetrical complications associated with abnormal maternal serum markers analytes. Journal of Obstetrics and Gynaecology Canada 30:918–949.
   PubMedGoogle Scholar
• Ghosh SK, Raheja S, Tuli A, Raghunandan C, Agarwal S. 2013. Is serum placental growth factor more effective as a biomarker in predicting early onset preeclampsia in early second trimester than in first trimester of pregnancy? Archives of Gynecology and Obstetrics 287:865–873.
   PubMed Web of Science ®Google Scholar
• Griffin M, Seed PT, Webster L, Myers J, MacKillop L, Simpson N, et al. 2015. Diagnostic accuracy of placental growth factor and ultrasound parameters to predict the small-for-gestational-age infant in women presenting with reduced symphysis-fundus height. Ultrasound in Obstetrics & Gynecology 46:182–190.
   PubMed Web of Science ®Google Scholar
• Grundy MA, Woodcock S, Attwood SE. 2008. The surgical management of obesity in young women: consideration of the mother's and baby's health before, during, and after pregnancy. Surgical Endoscopy 22:2107–2116.
   PubMed Web of Science ®Google Scholar
• Hauger MS, Gibbons L, Vik T, Belizán JM. 2008. Prepregnancy weight status and the risk of adverse pregnancy outcome. Acta Obstetricia et Gynecologica Scandinavica 87:953–959.
   PubMed Web of Science ®Google Scholar
• Hossain P, Kawar B, El Nahas M. 2007. Obesity and diabetes in the developing world-a growing challenge. The New England Journal of Medicine 356:213–215.
   PubMed Web of Science ®Google Scholar
• Livingston JC, Chin R, Haddad B, McKinney ET, Ahokas R, Sibai BM. 2000. Reductions of vascular endothelial growth factor and placental growth factor concentrations in severe preeclampsia. American Journal of Obstetrics and Gynecology 183:1554–1557.
   PubMed Web of Science ®Google Scholar
• Kiondo P, Wamuyu-Maina G, Bimenya GS, Tumwesigye NM, Wandabwa J, Okong P. 2012. Risk factors for pre-eclampsia in Mulago Hospital, Kampala, Uganda. Tropical Medicine & International Health. 17:480–487.
   PubMed Web of Science ®Google Scholar
• Kirkpatrick CA. 2010. The HELLP syndrome. Acta Clinica Belgica 65:91–97.
   PubMed Web of Science ®Google Scholar
• Li L, Zheng Y, Zhu Y, Li J. 2016. Serum biomarkers combined with uterine artery Doppler in prediction of preeclampsia. Experimental and Therapeutic Medicine 12:2515–2520.
   PubMed Web of Science ®Google Scholar
• Long PA, Abell DA, Beischer NA. 1979. Parity and pre-eclampsia. The Australian & New Zealand Journal of Obstetrics & Gynaecology 19:203–206.
   PubMed Web of Science ®Google Scholar
• Maeda Y, Kaneko K, Ogawa K, Sago H, Murashima A. 2021. The effect of parity, history of preeclampsia, and pregnancy care on the incidence of subsequent preeclampsia in multiparous women with SLE. Modern Rheumatology 31:843–848.
   PubMed Web of Science ®Google Scholar
• Mbah AK, Kornosky JL, Kristensen S, August EM, Alio AP, Marty PJ, et al. 2010. Super-obesity and risk for early and late pre-eclampsia. BJOG : An International Journal of Obstetrics and Gynaecology 117:997–1004.
   PubMed Web of Science ®Google Scholar
• Moore Simas TA, Crawford SL, Bathgate S, Yan J, Robidoux L, Moore M, et al. 2014. Angiogenic biomarkers for prediction of early preeclampsia onset in high-risk women. The Journal of Maternal-Fetal & Neonatal Medicine 27:1038–1048.
   PubMed Web of Science ®Google Scholar
• Ngwenya S, Jones B, Mwembe D. 2019. Determinants of adverse maternal and perinatal outcomes in severe preeclampsia and eclampsia in a low-resource setting, Mpilo Central Hospital, Bulawayo, Zimbabwe. BMC Research Notes 12:298.
   PubMed Web of Science ®Google Scholar
• Osanyin GE, Okunade KS, Oluwole AA. 2018. Association between serum CA125 levels in preeclampsia and its severity among women in Lagos, South-West Nigeria. Hypertension in Pregnancy 37:93–97.
   PubMed Web of Science ®Google Scholar
• Powe CE, Levine RJ, Karumanchi SA. 2011. Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease. Circulation 123:2856–2869.
   PubMed Web of Science ®Google Scholar
• Saffer C, Olson G, Boggess KA, Beyerlein R, Eubank C, Sibai BM, NORMALS Study Group. 2013. Determination of placental growth factor (PlGF) levels in healthy pregnant women without signs or symptoms of preeclampsia. Pregnancy Hypertension 3:124–132.
   PubMed Web of Science ®Google Scholar
• Shokry M, Bedaiwy MA, Fathalla MM, Alsemary A, Elwakil S, Murphy A. 2010. Maternal serum placental growth factor and soluble fms-like tyrosine kinase 1 as early predictors of preeclampsia. Acta Obstetricia et Gynecologica Scandinavica 89:143–146.
   PubMed Web of Science ®Google Scholar
• Sibai BM. 2003. Diagnosis and management of gestational hypertension and preeclampsia. Obstetrics and Gynecology 102:181–192.
   PubMed Web of Science ®Google Scholar
• Trogstad L, Magnus P, Stoltenberg C. 2011. Pre-eclampsia: risk factors and causal models. Best Practice & Research. 25:329–342.
   Web of Science ®Google Scholar
• Tsiakkas A, Duvdevani N, Wright A, Wright D, Nicolaides KH. 2015. Serum placental growth factor in the three trimesters of pregnancy: effects of maternal characteristics and medical history. Ultrasound in Obstetrics & Gynecology 45:591–598.
   PubMed Web of Science ®Google Scholar
• Wang A, Rana S, Karumanchi SA. 2009. Preeclampsia: the role of angiogenic factors in its pathogenesis. Physiology 24:147–158.
   PubMed Web of Science ®Google Scholar
• Wortelboer EJ, Koster MP, Cuckle HS, Stoutenbeek PH, Schielen PC, Visser GH. 2010. First-trimester placental protein 13 and placental growth factor: markers for identification of women destined to develop early-onset pre-eclampsia. BJOG: An International Journal of Obstetrics & Gynaecology 117:1384–1389.
   PubMed Web of Science ®Google Scholar